For years, doctors have told patients that exercise is good for the brain. Most people accepted that advice without knowing exactly why it was true. A new study published in the journal Cell has now answered that question at a biological level, and the findings are striking. Researchers at UC San Francisco have identified a specific chain of events that links physical activity in the body to protection of the brain against age-related damage and Alzheimer’s disease. At the center of this discovery is a pathway that runs from the liver to the brain, powered by a molecule your body produces when you move. What scientists found may change how Alzheimer’s research and treatment are approached for decades to come.
The Brain Has a Protective Shield, and Age Weakens It
Surrounding the brain is one of the most specialized structures in the human body: the blood-brain barrier. Made up of tightly packed cells lining the brain’s blood vessels, it acts as a selective filter, letting in nutrients and oxygen while keeping out toxins, pathogens, and harmful compounds circulating in the bloodstream.
With age, that barrier deteriorates. It becomes leaky. Substances that should never reach brain tissue start to seep through. Once inside, they trigger inflammation, damage neurons, and disrupt the molecular environment that memory and cognition depend on. Blood-brain barrier breakdown is not just a side effect of aging. Researchers now recognize it as one of the earliest measurable signs of Alzheimer’s disease, detectable in cerebrospinal fluid and neuroimaging studies years before any symptoms appear.
Senior author Saul Villeda, PhD, associate director of the UCSF Bakar Aging Research Institute, put it plainly: this discovery shows just how relevant the body is for understanding how the brain declines with age. For too long, Alzheimer’s research has focused almost entirely on what happens inside the brain. Villeda’s team started looking outside it.
Exercise Triggers a Liver Response That Reaches the Brain
Several years before this study, Villeda’s research team had already found something unusual. When mice exercised, their livers produced higher levels of an enzyme called GPLD1, short for glycosylphosphatidylinositol-specific phospholipase D1. Injecting this enzyme into sedentary aged mice improved their cognitive function, even though GPLD1 cannot cross the blood-brain barrier itself.
That created a puzzle. If the enzyme never enters the brain, how does it produce brain benefits? New experiments published in Cell in February 2026 provide the answer. GPLD1 does not need to enter the brain. Instead, it acts on the brain’s blood vessels from the outside, cleaning off a damaging protein that accumulates on those vessels as people age. By clearing that protein, GPLD1 restores the blood-brain barrier’s integrity, reduces inflammation inside the brain, and improves memory, all without ever crossing into brain tissue itself.
Meet TNAP: The Protein That Breaks Down the Brain’s Defenses
To find GPLD1’s target, researchers combed through databases of proteins that sit on the surface of cells. They were specifically looking for proteins anchored to the outer membrane by a molecular tag called GPI, the same type of anchor that GPLD1 cuts. GPLD1 can potentially cleave over 100 such proteins, so identifying the specific one responsible for the cognitive benefits requires careful, targeted testing.
When researchers screened proteins on brain endothelial cells, the cells that make up the blood-brain barrier, only one stood out as both a GPLD1 target and a protein that increases with aging: TNAP, or tissue-nonspecific alkaline phosphatase.
TNAP is an enzyme that plays roles in tissue mineralization and vascular function. As mice age, TNAP accumulates on the cells of the blood-brain barrier. With age, it builds up on the inner walls of the brain’s blood vessels, weakening their ability to control what passes through. When researchers reduced TNAP levels in two-year-old mice, the equivalent of a 70-year-old human, the blood-brain barrier became less permeable, inflammation in the brain dropped, and the animals performed better on memory tests.
Postdoctoral researcher Gregor Bieri, PhD, co-first author of the study, noted that researchers were able to tap into this mechanism late in life, and it still worked. Timing matters in medicine, and the fact that intervention at an equivalent human age of 70 still produced measurable recovery is a finding with real clinical weight.
How Researchers Confirmed TNAP Causes Cognitive Decline
To prove TNAP was the problem and not just a bystander, researchers ran a controlled experiment in young mice. Young mice do not normally have high TNAP levels in their brain’s blood vessels. Researchers genetically engineered young mice to produce excess TNAP there, mimicking the pattern seen in older animals.
Results were clear. Young mice with elevated blood-brain barrier TNAP showed increased barrier leakiness, reduced transport of important molecules into the brain, and measurable impairment in memory tests. Specifically, they struggled with object recognition tasks and spatial memory tasks that normal young mice handled easily.
When researchers then gave older mice increased liver-derived GPLD1, those mice improved on the same memory tasks. But when researchers simultaneously boosted TNAP back up in those older mice while giving them GPLD1, the cognitive benefits of GPLD1 disappeared. Blocking GPLD1’s ability to clear TNAP blocked its ability to protect memory. TNAP was not a coincidental finding. It was a direct driver of the cognitive decline that GPLD1 works against.
Blocking TNAP Works Like Exercise for the Brain
Once researchers established TNAP as the target, they tested whether blocking it pharmacologically could reproduce the benefits of exercise without requiring physical activity. Using an orally available TNAP inhibitor, they treated aged mice and compared results against aged mice given increased liver-derived GPLD1.
Both approaches produced comparable results. Blocking TNAP activity in aged mice improved object memory and spatial memory to a degree similar to what was seen with GPLD1 treatment. Single-cell genetic analysis of brain tissue confirmed that both interventions shifted the molecular profile of brain endothelial cells toward a younger state. Around 65 percent of gene expression changes produced by GPLD1 treatment were conserved with TNAP inhibition. Both approaches also reduced neuroinflammation and supported synaptic plasticity, the cellular process underlying learning and memory.
For older adults who cannot exercise due to physical limitations, illness, or disability, these findings open a potential therapeutic door. A drug that mimics the effects of exercise on the blood-brain barrier could one day deliver the brain-protective benefits of physical activity to people who are unable to achieve them through movement.
The Alzheimer’s Connection Goes Deeper Than Expected
Researchers extended the study into an established Alzheimer’s mouse model, the 5xFAD model, which carries mutations that cause accelerated amyloid beta buildup and early-onset cognitive decline. Mice in this model develop Alzheimer ‘s-like pathology before normal aging-related changes would appear.
When 5xFAD mice exercised voluntarily on running wheels for three months, their livers produced more GPLD1, and their performance on memory tests improved. Liver GPLD1 levels correlated with cognitive performance, meaning mice that produced more GPLD1 did better on tests.
When researchers increased liver GPLD1 directly in 5xFAD mice without exercise, amyloid beta deposits in the hippocampus decreased. Brain cells showed reduced signs of disease-associated inflammation. New neuron formation, which Alzheimer’s disease normally suppresses, increased. Levels of BDNF, a protein that supports synaptic strength and neuron survival, rose in treated mice.
Critically, researchers also found elevated TNAP in the brain tissue of older humans and of people with Alzheimer’s disease, compared to healthy young adults. What worked in mice appears to reflect a mechanism active in human aging and disease.
A Body-to-Brain Pathway That Alzheimer’s Research Has Overlooked
What makes this research significant beyond its immediate findings is what it suggests about where future Alzheimer’s treatments should look. Nearly all current Alzheimer’s drug development targets the brain directly, focusing on clearing amyloid plaques or tau tangles. Results from that approach have been mixed and often come too late in disease progression.
Villeda framed the implications directly: this work uncovers biology that Alzheimer’s research has largely overlooked, and it may open new treatment possibilities beyond strategies that focus almost exclusively on the brain.
Targeting the liver. Targeting the blood-brain barrier. Restoring vascular health in the brain by clearing proteins that accumulate with age. Each of these represents a strategy that does not require penetrating the brain directly, which has long been one of the greatest challenges in developing effective neurological therapies.
GPLD1 has also been found to increase in other biological contexts that extend lifespan, including caloric restriction and treatment with certain longevity-associated compounds. Researchers now believe its benefits may extend beyond cognitive protection to broader aging and longevity processes.
What This Means for You Right Now
Future drugs may one day replicate what exercise does to the liver and brain. But that day has not arrived yet, and the biology researchers identified tells a clear story about what is happening in your body every time you walk, run, swim, or cycle.
Exercise raises GPLD1 in the liver. GPLD1 travels through the bloodstream to the brain’s blood vessels. It strips TNAP off those vessel walls, sealing the blood-brain barrier, reducing inflammation, and supporting the molecular environment that memory depends on. Every workout is a maintenance session for your brain’s most important defense system.
That is not a metaphor. It is a biochemical chain of events that researchers can now trace step by step from muscle to liver to blood vessel to brain.
My Personal RX on Protecting Your Brain From Alzheimer’s Through Exercise and Lifestyle
As a doctor who has watched patients lose their memories to Alzheimer’s disease, I find this research deeply meaningful. For the first time, we can see exactly how exercise reaches into the brain and repairs the damage that aging inflicts on its protective barriers. What I want every patient and reader to understand is this: the actions you take in your body today are building or breaking down your brain’s defenses for tomorrow. Alzheimer’s does not begin with a diagnosis. It begins decades earlier, with the slow deterioration of the blood-brain barrier, the buildup of inflammatory proteins, and the loss of the molecular signals that keep neurons healthy and connected. Exercise fights all of those processes at once. When physical limitations make exercise difficult, gut health, nutrition, sleep, and stress management all support the same underlying systems. You have more control over your brain’s future than you may realize. Start using it.
- Move Daily to Raise GPLD1 Naturally: Aerobic exercise is the most direct way to raise liver GPLD1 production. Aim for at least 150 minutes of moderate aerobic activity per week. Walking, cycling, swimming, and dancing all count. Consistency matters more than intensity.
- Prioritize Deep Sleep to Clear Brain Waste: During sleep, the brain’s glymphatic system activates and clears metabolic waste products, including amyloid beta, the protein that accumulates in Alzheimer’s disease. Sleep Max combines magnesium, GABA, 5-HTP, and taurine to support deep, restorative sleep so your brain can run its nightly repair cycle.
- Control Blood Pressure and Blood Sugar: High blood pressure and insulin resistance both damage the blood-brain barrier. Regular cardiovascular exercise, a low-glycemic diet, and weight management all reduce vascular stress on the brain’s protective cells.
- Know Your Key Nutrients After 40: Deficiencies in omega-3 fatty acids, vitamin D, B12, magnesium, and zinc all contribute to neuroinflammation and cognitive decline. Download The 7 Supplements You Can’t Live Without, a free guide covering the nutrients that matter most for brain protection, energy, and memory after 40.
- Reduce Alcohol Intake: Alcohol increases blood-brain barrier permeability and promotes neuroinflammation. Even moderate regular drinking accelerates the vascular aging that this research identifies as a primary driver of cognitive decline.
- Stay Socially and Cognitively Active: Mental engagement supports synaptic plasticity and may offset some of the gene expression changes that accumulate with age in the hippocampus. Learning new skills, maintaining social relationships, and engaging in mentally demanding activities all contribute to brain resilience.
- Manage Chronic Stress Aggressively: Elevated cortisol increases blood-brain barrier permeability and promotes the kind of neuroinflammation that TNAP buildup contributes to. Daily stress reduction through breathwork, meditation, or time in nature lowers the baseline inflammatory burden your brain carries.
- Know Your Family History and Act Early: If Alzheimer’s disease runs in your family, start brain-protective habits now, not at 60 or 70. Vascular changes in the brain begin decades before symptoms appear. Every year of regular exercise, quality sleep, and anti-inflammatory nutrition you build now lowers your biological risk going forward.
Source: Bieri, G., Pratt, K. J., Fuseya, Y., Aghayev, T., Sucharov, J., Horowitz, A. M., Philp, A. R., Fonseca-Valencia, K., Chu, R., Phan, M., Remesal, L., Wang, S. J., Yang, A. C., Casaletto, K. B., & Villeda, S. A. (2026). Liver exerkine reverses aging- and Alzheimer’s-related memory loss via vasculature. Cell, 189(5), 1499-1516.e25. https://doi.org/10.1016/j.cell.2026.01.024
Subscribe to Ask Dr. Nandi YouTube Channel
